Intellipharmaceutics International Inc. (IPCI)

[doogdilinger]

I will lmfao when the sizable IPCI short gets squeezed on the next FDA approval.

Beyond hilarious how with 3 pending FocalinXR strengths all set to be FDA approved most likely by/b4 years end, at least 1 of their 2 5+ year old other pending ANDA's set to be FDA approved within the next 6 months maximum...and Rexista bioequivalence and the Rexista global partner announcement most definitely both to arrive within the next 6 months...the market has IPCI priced for total and complete failure lol.

When the truth is if not for the faulty manufactured Focalin products out there from other inferior companies/manufacturers...the FDA never would've been in the position to flip-flop on IPCI's Focalin bioequivalence requirement...and we'd probably already be trading somewhere between $6 and $8 per share with anticipation building towards Rexista partnership and Rexista bioequivalence submission during the 1st 3 months of 2016.

For those keeping track of the real progress/developments ongoing behind the scenes with IPCI and the FDA...the $2 share price is a complete and utter joke...considering exactly 1 year from right now IPCI will have 5 strengths of FocalinXR being sold instead of the 2 currently...will have at least 1 and most likely 2 more FDA ANDA approvals already along with full commercialization launched by their still to be announced licensing partners...and the biggest catalyst of them all...they could already have Rexista FDA approval and full commercialization of Rexista launched by their global partner!!!

None of the pending catalysts just listed in the above paragraph are a pipe dream...in fact ALL of them should hit...and 1 year from today IPCI's share price will be somewhere north of $30 per share being accumulated by all kinds of funds and institutions!

So let the market continue to doubt because the majority of us know what we own and know what's coming choo-choo:)